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Abstract
Background: Cerebral hypoperfusion may aggravate neurological damage after cardiac arrest. Near-infrared
spectroscopy (NIRS) provides information on cerebral oxygenation but its relevance during post-resuscitation
care is undefined. We investigated whether cerebral oxygen saturation (rSO2) measured with NIRS correlates
with the serum concentration of neuron-specific enolase (NSE), a marker of neurological injury, and with clinical
outcome in out-of-hospital cardiac arrest (OHCA) patients.
Methods: We performed a post hoc analysis of a randomised clinical trial (COMACARE, NCT02698917) comparing two
different levels of carbon dioxide, oxygen and arterial pressure after resuscitation from OHCA with ventricular fibrillation
as the initial rhythm. We measured rSO2 in 118 OHCA patients with NIRS during the first 36 h of intensive care. We
determined the NSE concentrations from serum samples at 48 h after cardiac arrest and assessed neurological outcome
with the Cerebral Performance Category (CPC) scale at 6months. We evaluated the association between rSO2 and serum
NSE concentrations and the association between rSO2 and good (CPC 1–2) and poor (CPC 3–5) neurological outcome.
Results: The median (inter-quartile range (IQR)) NSE concentration at 48 h was 17.5 (13.4–25.0) μg/l in patients with good
neurological outcome and 35.2 (22.6–95.8) μg/l in those with poor outcome, p < 0.001. We found no significant
correlation between median rSO2 and NSE at 48 h, rs = − 0.08, p = 0.392. The median (IQR) rSO2 during the first 36 h of
intensive care was 70.0% (63.5–77.0%) in patients with good outcome and 71.8% (63.3–74.0%) in patients with poor
outcome, p = 0.943. There was no significant association between rSO2 over time and neurological outcome. In a binary
logistic regression model, rSO2 was not a statistically significant predictor of good neurological outcome (odds ratio 0.99,
95% confidence interval 0.94–1.04, p = 0.635).
Conclusions: We found no association between cerebral oxygenation measured with NIRS and NSE concentrations or
outcome in patients resuscitated from OHCA.
Trial registration: ClinicalTrials.gov, NCT02698917. Registered on 26 January 2016.
Keywords: Cardiac arrest, Cerebral oxygenation, Hypoxic ischemic encephalopathy, Intensive care, Neuron-specific
enolase (NSE)
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Background
Cerebral hypoperfusion may lead to diminished cerebral
oxygenation after initially successful resuscitation from car-
diac arrest (CA). Inadequate oxygenation plausibly aggra-
vates the developing neurological injury [1]. Near-infrared
spectroscopy (NIRS) provides a non-invasive technique to
assess cerebral oxygenation [2], and the changes in regional
cerebral oxygen saturation (rSO2) are considered to reflect
changes in the relationship between oxygen delivery and
consumption in the brain [3]. An increasing body of
evidence suggests that optimised cerebral oxygenation is
associated with favourable neurologic outcome in a variety
of perioperative settings [4]. In addition, higher rSO2 is
associated with increased probability of return of spon-
taneous circulation (ROSC) during cardiopulmonary resus-
citation (CPR) [5]. However, the clinical relevance of NIRS
during post-resuscitation care remains undefined.
In previous studies including both in-hospital and
out-of-hospital cardiac arrest (OHCA) patients, higher
rSO2 values during the early post-resuscitation care were
associated with better neurological outcome [6, 7]. On the
contrary, in studies including only OHCA patients, the
results have been conflicting [8, 9]. We recently published
the results of a randomised pilot trial (Carbon dioxide,
Oxygen and Mean arterial Pressure After Cardiac Arrest
and REsuscitation (COMACARE)) comparing the effect of
different levels of arterial carbon dioxide tension (PaCO2),
arterial oxygen tension (PaO2) and mean arterial pressure
(MAP) on surrogate markers of brain injury and on
cerebral oxygenation after OHCA. We found that both
high-normal PaCO2 and moderate hyperoxia increased
rSO2 values but the serum neuron-specific enolase (NSE)
concentration was unaffected [10], and the MAP level had
no impact on either rSO2 or NSE [11].
In the current study, a post hoc analysis of the COMA-
CARE trial, we assessed the associations between cerebral
oxygenation and serum neuron-specific enolase (NSE) con-
centrations and between cerebral oxygenation and neuro-
logical outcome in patients resuscitated from ventricular
fibrillation (VF) or ventricular tachycardia (VT).
Methods
All patients included in this post hoc sub-study were
participants of the COMACARE trial (NCT02698917).
The COMACARE trial protocol and the main results have
been published previously [10–12]. In brief, 123 uncon-
scious, mechanically ventilated patients resuscitated from
witnessed OHCA with VF or VT as the initial rhythm were
randomly assigned to one of eight arms with each arm
having a different combination of targets for PaCO2, PaO2
and MAP. All patients were treated with targeted
temperature management (TTM), and the randomisation
was stratified according to the target temperature (33 °C or
36 °C). The intervention was continued for 36 h from
intensive care unit (ICU) admission or until the patient
was extubated or ventilation was set to a spontaneous
mode.
The study protocol was approved by the research ethics
committees of the Northern Savo Hospital District, Finland
(decision No. 295/2015), and the Midtjylland region,
Denmark (decision No. 1-10-72-163-16). In addition, the
trial protocol was approved by the institutional review
board at each site. Because of the nature of the trial, the
patients’ unconscious state and the need for a timely inter-
vention, obtaining prior informed consent from the partici-
pants at the time of randomisation was not possible.
Therefore, a deferred consent procedure was approved by
the research ethics committee. We randomised the patients
and initiated the intervention at the time of ICU admission
and obtained deferred informed consent from the patients’
next of kin afterwards as soon as possible. In addition, we
obtained informed consent from all patients who regained
sufficient neurological function for independent decision-
making [Cerebral Performance Category (CPC) 1–2] after
the intervention period.
We measured rSO2 with continuous NIRS during the
first 36 h of intensive care using a Covidien INVOS 5100C
device (Covidien Company, USA). Two non-invasive skin
sensors, one to each side, were attached to the patient’s
forehead by a study nurse according to the instructions of
the manufacturer. As NIRS monitoring was not part of
routine care in the participating ICUs, the treating
personnel were blinded from the rSO2 values. Thus,
NIRS monitoring results did not affect patient care. We
saved the rSO2 values (approximately 10 measurements
per minute) from both sensors to a USB memory stick
attached to the device. We calculated the hourly me-
dians of these rSO2 values of the left channel and used
them in the analyses.
The primary endpoint in this study was serum NSE
concentration at 48 h after CA. We obtained blood
samples for the analyses of the NSE concentrations
upon ICU admission and 24 h, 48 h and 72 h after CA.
In the Finnish centres, the samples were centrifuged
(2000 g, 10 min) and the serum was frozen at − 70 °C at
the hospital laboratory. The measurements of the NSE
concentrations were done in ISLAB laboratories (Kuopio,
Finland) using a COBAS e601 line (Hitachi High Techno-
logy Co, Tokyo, Japan) with an electrochemiluminescent
immunoassay kit (Roche Diagnostics GmbH, Mannheim,
Germany) in January 2018. Because of possible inter-
ference of haemolysis with NSE results, all serum
samples were tested for haemolysis using the Roche
haemolysis index [13], and all samples with a haemo-
lysis index ≥ 50 (corresponding to 500mg of free haemo-
globin per litre) (n = 7) were excluded from the NSE
analyses. At the Aarhus University Hospital, Denmark, the
blood samples were analysed immediately by the local
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laboratory using the same kits as those used by the ISLAB
laboratory.
The secondary endpoint was neurological outcome
assessed with the CPC scale at 6 months after CA. We
defined CPC 1–2 as good outcome and CPC 3–5 as
poor outcome. One experienced neurologist, blinded to
study group allocation, interviewed all patients or their
next of kin by telephone and determined the neurologic
outcome using the CPC scale.
Statistical methods
We compared the categorical data between patients with
good and poor outcome by using the Chi-square test. We
tested the normality of the continuous data with the
Kolmogorov-Smirnov test and compared the data with a
normal distribution with the Student t test and the data
with a non-normal distribution with the Mann–Whitney U
test (MWU). We compared the median NSE concentra-
tions at 48 h after CA between patients with good and poor
neurological outcome at 6months using the MWU. We
calculated the median rSO2 during the first 36 h of inten-
sive care for each patient and then assessed the possible
relationship between the median rSO2 and NSE concentra-
tions at 24, 48 and 72 h using a scatterplot and Spearman’s
rank-order correlation. We compared the 36-h medians
between patients with good and those with poor outcome
using the MWU. We compared the rSO2 over time
between patients with good and those with poor outcome
using a generalised mixed model with a compound-sym-
metry covariance matrix. We used binary logistic regression
model to ascertain the effects of baseline factors and rSO2
on the likelihood of good neurological outcome. We chose
to model those factors that were significantly associated
with prognosis (p < 0.05) in univariate analysis. These fac-
tors were age, bystander-initiated resuscitation, delay from
collapse to return of spontaneous circulation (ROSC) and
Acute Physiology and Chronic Health Evaluation (APA-
CHE) II score (Table 1). Finally, we divided the cohort into
tertiles according to the lowest 60-min median rSO2 during
the 36-h period and calculated the probability for a good
outcome with 95% confidence interval for each tertile. In
addition, we calculated the area under the receiver operat-
ing characteristic curve with 95% confidence interval for
the lowest 60-min median rSO2 to predict good outcome
in each tertile. We performed all statistical analyses
with SPSS version 24.0 (IBM Corporation, USA).
Results
The flowchart demonstrating patient enrolment is
presented in Fig. 1. The patient recruitment began on 22
March 2016 and was completed by 3 November 2017.
The 6-month-follow-up of the last patient was completed
by 3 May 2018. The baseline characteristics and
resuscitation-associated factors according to the 6-month
neurological outcome are presented in Table 1.
The median (inter-quartile range (IQR)) NSE concentra-
tion at 48 h was 17.5 (13.4–25.0) μg/l and 35.2 (22.6–95.8)
μg/l in patients with good and poor neurological outcome,
respectively, p < 0.001. We found no statistically sig-
nificant correlation between median rSO2 during the first
36 h in the ICU and serum NSE concentration at 48 h
after CA, rs = − 0.08, p = 0.392 (Fig. 2). In addition, there
was no correlation between median rSO2 during the first
36 h in the ICU and serum NSE concentrations at 24 h or
72 h after CA (Additional file 1).
The median (IQR) rSO2 during the first 36 h of inten-
sive care was 70.0% (63.5–77.0%) in patients with good
neurological outcome and 71.8% (63.3–74.0%) in pa-
tients with poor neurological outcome, p = 0.943. There
was no significant association between rSO2 over time
and neurologic outcome (Fig. 3). In the binary logistic
regression model, the median rSO2 during the first 36 h
in the ICU was not a statistically significant predictor of
good outcome (adjusted odds ratio 0.99, 95% confidence
interval 0.94–1.04, p = 0.635). Additionally, the worst
60-min median rSO2 did not associate with good neuro-
logical outcome (Table 2).
Discussion
We prospectively monitored rSO2 with NIRS monitoring
for 36 h after ICU admission in 118 patients resuscitated
from OHCA with VF or VT as initial rhythm. This is, to
our knowledge, the largest cohort of post-resuscitation
patients with continuous NIRS monitoring during the early
intensive care so far, and it is the only cohort including
patients exclusively with shockable initial rhythms. We did
not find any significant association between rSO2 and NSE
concentrations at 48 h after CA, nor between rSO2 and
neurological outcome at 6months. Our findings question
the role of routine NIRS monitoring in these patients.
Pursuing optimal brain oxygenation appears as an
intuitively appealing strategy during post-resuscitation care
[14, 15]. Despite its limitations, NIRS provides a non-inva-
sive method to continuously monitor cerebral tissue oxy-
gen saturation in a part of the frontal cortex and to detect
clinically silent episodes of cerebral ischaemia [2]. Based
on its already widespread use in different perioperative set-
tings and the promising results of rSO2 as a predictor of
ROSC during CPR, the expectations have been high that
the information provided by NIRS could facilitate opti-
misation of the treatment of resuscitated patients and pro-
vide a feasible target for goal-directed therapy after CA.
The results of previous studies assessing the association
between cerebral oxygenation during post-resuscitation care
and outcome have been controversial [6–9]. We assessed the
possible association between post-resuscitation rSO2 and
long-term neurological outcome in a defined population of
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Table 1 Baseline characteristics of the study population according to good (CPC 1–2) or poor (CPC 3–5) 6-month neurological
outcome
CPC Cerebral Performance Category [1, good cerebral performance (normal life); 2, moderate cerebral disability (disabled but independent); 3, severe cerebral
disability (conscious but disabled and dependent); 4, coma or vegetative state (unconscious); 5, brain death]; SD standard deviation, IQR inter-quartile range; NYHA
New York Heart Association; CPR cardiopulmonary resuscitation; ICU intensive care unit; GCS Glasgow Coma Scale; ROSC return of spontaneous circulation; APACHE
Acute Physiology and Chronic Health Evaluation
aData missing for 2 patients
bData missing for 13 patients
cData missing for 9 patients
1The time for a paramedic unit with BLS equipment and skills to reach the patient
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CA patients with shockable initial rhythm and a relatively
good prognosis, with 66% of the patients achieving good
neurological outcome. In previous studies that found an as-
sociation between NIRS values and outcome after CA, the
overall rate for good neurological recovery (CPC 1–2) has
been 38–47% [7, 9]. It is possible that the larger proportion
of patients with poor outcome in these cohorts than in our
study population may explain the different results.
In the COMACARE trial, high-normal PaCO2 and mod-
erate hyperoxia significantly increased rSO2 values during
the first 36 h of intensive care [10]. However, there was no
difference in serum NSE concentrations at 24, 48 or 72 h
after CA or neurological outcome at 6 months between
any of the intervention groups. This supports the view
that achieving higher rSO2 does not necessarily improve
chances for good recovery. In many surgical settings,
NIRS is used as a perioperative monitor, and changes of
15–20% from the baseline values are considered meaning-
ful [3]. By contrast, in CA patients, the normal baseline is
unknown and the optimal or even minimal level of rSO2
for optimal recovery remains unidentified. In addition, it is
possible that the extent of the neuronal damage during CA
is the major determinant of outcome and all the secondary
changes in cerebral blood flow (CBF) after ROSC have only
a minor effect on the patient’s prognosis. One may also
speculate that increasing oxygen delivery to the brain does
not necessarily mean that the damaged neurons are able to
utilise oxygen better [16].
Fig. 1 Screened, excluded and included patients in the study
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RSO2 is thought to reflect CBF, and a recent study
found a moderate correlation between rSO2 and cerebral
perfusion pressure (CPP) [17]. However, the significance
of optimising CPP and CBF to improve outcomes during
post-resuscitation care remains undefined. In another
study assessing CBF with serial duplex ultrasound
measurements after CA, there was no association be-
tween CBF and outcome [18], which is in accordance
with our finding of the lack of correlation between rSO2
and outcome. Interestingly, a correlation was found be-
tween the systemic blood pressure and CBF in patients
with poor outcome, suggesting that impaired autoregula-
tion of CBF during post-resuscitation care is related to
poor prognosis. Impaired autoregulation during the first
24 h after CA has indeed been previously associated with
poor outcome [19]. It is possible that rSO2 monitoring
might be useful in the assessment of autoregulation, but
more research is needed to determine its role.
Fig. 2 Scatter plots of serum neuron-specific enolase (NSE) concentration at 48 h after cardiac arrest vs. median regional cerebral oxygen
saturation (rSO2) during the first 36 h in intensive care unit in patients with good (Cerebral Performance Category [CPC] 1–2) and poor (CPC 3–5)
neurological outcome
Fig. 3 Median (inter-quartile range) regional cerebral oxygen saturation (rSO2) during the first 36 h of intensive care in patients with good
(Cerebral Performance Category [CPC] 1–2) and poor (CPC 3–5) neurological outcome
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The current study has several strengths. First, this was a
large cohort of resuscitated patients with continuous NIRS
monitoring. Second, we assessed the association of cerebral
oxygenation with outcome in patients resuscitated from exclu-
sively shockable initial rhythms. Third, we used continuous
NIRS monitoring applied soon after ICU admission and con-
tinued for 48 h. Fourth, the physicians and ICU personnel re-
sponsible for the intensive care of the study patients were
blinded to the NIRS monitor readings. Fifth, we treated all pa-
tients according to the current guidelines for post-
resuscitation intensive care including targeted temperature
management at either 33 °C or 36 °C. Finally, we studied pa-
tients in multiple centres and in two different countries.
Our study has some limitations. First, the design of this
sub-study was conceived post hoc and was not included in
the original COMACARE protocol [12]. Second, we did not
assess CBF by transcranial Doppler ultrasound. As rSO2 is a
surrogate indicator of CBF, transcranial Doppler could have
provided additional information. Third, we used NIRS
probes attached on the patients’ forehead which provides in-
formation about a small area of the frontal cerebral cortex,
leaving other parts of the brain uncovered. Thus, we cannot
exclude regional variation in rSO2 which could have caused
bias to our results. Fourth, the fact that we studied a rela-
tively selected population of CA patients with only shockable
initial rhythms limits the generalisability of the results. Fi-
nally, although we studied patients in multiple centres, a ma-
jority were recruited in one hospital.
Conclusions
We did not find any association between cerebral oxi-
metry (rSO2) during the first 36 h of post-resuscitation
intensive care and NSE serum concentrations at 48 h
after OHCA or neurological outcome at 6 months.
Additional file
Additional file 1: Association between rSO2 and the NSE concentrations at
24 h and 72 h. The scatterplots and the results of the Spearman rank order
correlation analyses concerning the associations between rSO2 and the serum
NSE concentrations at 24 h and 72 h after cardiac arrest. (PDF 171 kb)
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